SENSEX    72500.3       195.42    |    NIFTY    21982.8       31.65 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
TCS, Infosys, Dr. Reddy's Lab, Voltas to be watched
17-Mar-23   08:50 Hrs IST

TCS: Rajesh Gopinathan, Chief Executive Officer and Managing Director of Tata Consultancy Services (TCS) has tendered his resignation, which will be effective from the close of business hours on 15 September 2023. The Board of Directors appointed K. Krithivasan as the Chief Executive Officer Designate, with effective from 16 March 2023. He shall take over as the Chief Executive Officer and Managing Director of the Company in the next financial year.

Infosys: Infosys Finacle, part of EdgeVerve Systems, a fully owned subsidiary of Infosys and ABN AMRO, a leading financial services provider in the Netherlands, announced the implementation and go-live of the Infosys Finacle Liquidity Management Solution for the bank's corporate customers.

Dr. Reddy's Laboratories: The company along with its subsidiaries announced the signing of a deal to divest certain non-core brands of the company in the dermatology segments to Eris Lifesciences. Under the agreement, Eris Lifesciences will be assigned the trademark of these brands by Dr. Reddy's for a consideration of Rs. 275 crore.

Voltas: Universal MEP Projects & Engineering Services (UMPESL), a 100% subsidiary of Voltas has bagged multiple SITC project orders worth about Rs 1770 crore in the Electrical Power Distribution business for FY 22-23, including a solar power project.

Glenmark Pharmaceuticals: Glenmark Specialty SA, the subsidiary of Glenmark Pharmaceuticals received acceptance from the U.S. Food and Drug Administration (FDA) on its Investigational New Drug application to proceed with a Phase 1/2, first-in-human, clinical study of for the treatment of patients with advanced solid tumors and lymphomas.

Ircon International (IRCON): IRCON has furnished Corporate Guarantee to SBICAP Trustee Company Limited for providing the Term Loan from State Bank of India to IrconHBL, Special Purpose Vehicles (SPVs) & wholly owned subsidiaries of IRCON.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 89.93 1.08
United Kingdom (GBP) 1.17 1.00 105.12 1.27
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.92 0.79 82.89 1.00
Market News << ALL News
  29-Feb-2024, (05:31 )  Exicom Telesystems I..
  29-Feb-2024, (03:00 )  Max Healthcare Insti..
  29-Feb-2024, (02:58 )  Transindia surges af..
  29-Feb-2024, (02:45 )  Flexituff Ventures I..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)